SLC2A1 and hepatocellular carcinoma: Recent research reveals that SLC2A1-AS1 plays a critical role in inhibiting glycolysis and HCC progression by reducing the mRNA and protein expression of GLUT1, thereby rendering GLUT1 inactive [69].